Verastem Announces Start of Late-stage Trial for Meso Drug
The company’s president hopes they’ll be filing for FDA approval by the end of the trial.
Category: life expectancy
Experimental Breast Cancer Drug Shows Promise in Treating NSC Lung Cancer
A clinical trial using PARP inhibitors to treat breast and ovarian cancers actually showed promise in the treatment of some forms of lung cancer